Nivolumab-induced interstitial lung disease in the patient with melanoma
This article presents the case of a drug-induced interstitial lung disease in response to nivolumab, which is a programmed death receptor 1 (PD1) blocking antibody. A 66 year-old-man with metastatic melanoma of the scalp was treated with monthly nivolumab infusions at a dose of 480 mg. After 23 dose...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2024-02-01
|
| Series: | Alergologia Polska |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Nivolumab-induced-interstitial-lung-disease-in-the-patient-with-melanoma,123,52434,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|